Velasco Ortega, EugenioSierra Baztan, AngelaJiménez Guerra, AlvaroEspaña López, AntonioOrtiz García, IvanNúñez Márquez, EnriqueMoreno Muñoz, JesúsRondón Romero, José LuisLópez López, José, 1958-Monsalve Guil, Loreto2021-11-022021-11-022021-09-221660-4601https://hdl.handle.net/2445/180967Introduction: The aim of this study was to show the long-term clinical outcomes of implants placed in maxillary sinus floor augmentation (MFSA) using beta-tricalcium phosphate (β-TCP). Patients and methods: Maxillary patients were diagnosed for MFSA and used beta- β-TCP. After the lateral sinus surgery, implants were loaded at 6 months with restorations. The clinical follow-up was at 10 years. Results: One hundred and one patients (58 females and 43 males) were treated with MFSA. Twenty-nine patients (28.7%) had a history of periodontitis. Thirty-three patients (32.7%) were smokers. One hundred and twenty-one MFSA, 81 unilateral and 20 bilateral sites, with 234 implants were performed. The average vertical bone height available was 4.92 ± 1.83 mm. The average vertical bone gain obtained was 6.95 ± 2.19 mm following MFSA. The implant cumulative survival rate was 97.2%. Three implants (1.3%) were lost during the healing period. Six implants (2.6%) were lost by peri-implantitis. One hundred and fifteen restorations were placed in the patients. Mean marginal bone loss was 1.93 mm ± 1.03 mm. Six patients (27.3%) showed technical complications. Thirty-six implants (15.3%) in 14 patients (13.9%) were associated with peri-implantitis. Conclusions: This study indicates that treatment with implant-supported restoration by MFSA using β-TCP constitutes a successful implant approach.14 p.application/pdfengcc by (c) Velasco Ortega, Eugenio, 2021http://creativecommons.org/licenses/by/3.0/es/PeriodontitisPròtesis internesPeriodontitisStents (Surgery)info:eu-repo/semantics/article2021-10-28info:eu-repo/semantics/openAccess34639277